6月27日,华润双鹤药业股份有限公司发布公告,宣布其控股股东北京医药集团有限责任公司(北药集团)的股权结构发生变动。变动内容为,北药集团的原控股股东华润医药投资有限公司将其持有的北药集团51%股权无偿划转至华润医药控股有限公司,并已完成工商变更登记。在此之前,华润先后收购天士力、增资浙江震元医药等。不断加码自身硬实力。与此同时,同为医药巨头的另一央企,国药集团近期也频频加大整合力度,如收购派林生物...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.